Nivalis Throttled After Failed Drug Trial, Multiple Downgrades
November 29, 2016 at 11:07 AM EST
Nivalis Therapeutics Inc (NASDAQ: NVLS) shares are trading lower by $3.60 (57 percent) at $2.65 in Tuesday's session. After ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.